by pbn | May 20, 2024 | Press Releases
2N Pharma CEO, Preben Bruun-Nyzell, and CSO, Dr John Nieland, will participate in the 3rd ALS Drug Development Summit in Boston, 21-23 May 2024. This is a fantastic opportunity to engage with the world’s leading ALS drug development companies.
by pbn | Jan 24, 2023 | Press Releases
Congratulations to Dr Michael Sloth Trabjerg MD, 2N Pharma Co-Founder, CSO and Aalborg University Associate Professor Dr John Dirk Vestergaard Nieland, and collaborators on the publication of their newest article in npj Parkinson’s Disease. The article details their...
by pbn | Dec 1, 2022 | Press Releases
We are so happy that WAPO published an article about the extremely interesting work being carried out by Dr Dina Dechmann, Dr Liliana Dávalos, and 2N Pharma CSO and Aalborg University associate prof. Dr John Dirk Vestergaard Nieland. In the winter, the...
by Nicole Overmars | May 3, 2022 | Press Releases
Aalborg – We are pleased to announce that Preben Bruun Nyzell has been invited to the Anglonordic Life Science Conference that takes place in London on May 4-5. About Anglonordic The Anglonordic Life Science Conference is an investment and partnering...
by Nicole Overmars | Apr 12, 2022 | Press Releases
Aalborg – US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. 2N Pharma is thrilled to announce that the US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. We are extremely grateful for the financial support that will...
by Nicole Overmars | Apr 5, 2022 | Press Releases
Boston – We are thrilled to announce that Preben Bruun-Nyzell and John Nieland will attend DKBIO 2022 in Boston on April 6-7. About DKBIO Innovation Centre Denmark and the Danish Ministry of Foreign Affairs are hosting DKBIO 2022. One of our investors,...
Recent Comments